(S1 (S (NP (NP (NP (NN Overexpression)) (PP (IN of) (NP (NP (NN Forkhead) (NN Box) (NN M1) (NN transcription) (NN factor)) (CC and) (NP (JJ nuclear) (NN factor-kappaB)))) (PP (IN in) (NP (JJ laryngeal) (JJ squamous) (NN cell) (NN carcinoma)))) (: :) (NP (NP (DT a) (JJ potential) (NN indicator)) (PP (IN for) (NP (JJ poor) (NN prognosis)))) (. .))))
(S1 (S (S (NP (NP (DT The) (NN Forkhead) (NN Box) (NN M1) (NN transcription) (NN factor)) (CC and) (NP (JJ nuclear) (NN factor-kappaB))) (VP (VBP have) (VP (VBN been) (VP (VBN shown) (S (VP (TO to) (VP (VB play) (NP (JJ important) (NNS roles)) (PP (IN in) (NP (NP (DT the) (NP (NN development)) (CC and) (NP (NN progression))) (PP (IN of) (NP (JJ human) (NNS cancers)))))))))))) (. .)))
(S1 (S (S (ADVP (RB However)) (, ,) (NP (NP (NP (DT the) (JJ functional) (NN significance)) (PP (IN of) (NP (NP (NN Forkhead) (NN Box) (NN M1) (NN transcription) (NN factor)) (PP (IN in) (NP (JJ laryngeal) (JJ squamous) (NN cell) (NN carcinoma)))))) (CC and) (NP (NP (DT the) (NN correlation)) (PP (IN between) (NP (NP (NN Forkhead) (NN Box) (NN M1) (NN transcription) (NN factor)) (CC and) (NP (JJ nuclear) (NN factor-kappaB)))))) (VP (VBP remain) (ADJP (JJ unclear)))) (. .)))
(S1 (S (PP (IN In) (NP (DT the) (JJ current) (NN study))) (, ,) (NP (PRP we)) (VP (VBP have) (VP (VBN shown) (SBAR (IN that) (S (NP (NP (NN Forkhead) (NN Box) (NN M1) (NN transcription) (NN factor)) (CC and) (NP (JJ nuclear) (NN factor-kappaB))) (VP (VBD were) (ADVP (RB significantly)) (VP (VBN overexpressed) (PP (IN in) (NP (NP (NP (JJ laryngeal) (JJ squamous) (NN cell) (NN carcinoma)) (NNS tissues)) (CC and) (NP (JJ precancerous) (NNS lesions)))) (, ,) (PP (VBN compared) (PP (IN with) (NP (NP (JJ adjacent) (JJ normal) (NNS tissues)) (PRN (-LRB- -LRB-) (CC both) (NP (NN P) (NN <) (CD .001)) (-RRB- -RRB-))))))))))) (. .)))
(S1 (S (S (NP (NP (DT The) (NN overexpression)) (PP (IN of) (NP (NN Forkhead) (NN Box) (NN M1) (NN transcription) (NN factor)))) (VP (VBD was) (ADVP (RB significantly)) (VP (VBN associated) (PP (IN with) (NP (NP (NP (JJ histologic) (NN differentiation)) (PRN (-LRB- -LRB-) (NP (NN rs) (JJ =) (CD 0.321)) (, ,) (NP (NN P) (JJ =) (NN .002)) (-RRB- -RRB-))) (, ,) (NP (NP (NN T) (NN stage)) (PRN (-LRB- -LRB-) (NP (NN rs) (JJ =) (NN 0.276)) (, ,) (NP (NN P) (JJ =) (CD .009)) (-RRB- -RRB-))) (, ,) (NP (NP (NN lymph) (NN node) (NN metastasis)) (PRN (-LRB- -LRB-) (NP (NN rs) (JJ =) (NN 0.266) (, ,) (NN P) (JJ =) (NN .012)) (-RRB- -RRB-))) (, ,) (CC and) (NP (JJ clinical) (NN stage)))) (PRN (-LRB- -LRB-) (NP (NN rs) (JJ =) (CD 0.272)) (, ,) (NP (NN P) (JJ =) (CD .010)) (-RRB- -RRB-))))) (: ;) (S (NP (NP (NN overexpression)) (PP (IN of) (NP (JJ nuclear) (NN factor-kappaB)))) (VP (VBD was) (ADVP (RB significantly)) (VP (VBN associated) (PP (IN with) (NP (NP (NP (NN T) (NN stage)) (PRN (-LRB- -LRB-) (NP (NN rs) (JJ =) (NN 0.404)) (, ,) (NP (NN P) (NN <) (CD .001)) (-RRB- -RRB-))) (, ,) (NP (NP (NP (NN lymph) (NN node)) (NN metastasis)) (PRN (-LRB- -LRB-) (NP (NN rs) (JJ =) (NN 0.293) (, ,) (NN P) (JJ =) (NN .005)) (-RRB- -RRB-))) (, ,) (CC and) (NP (NP (JJ clinical) (NN stage)) (PRN (-LRB- -LRB-) (NP (NN rs) (JJ =) (CD 0.425)) (, ,) (NP (NN P) (NN <) (CD .001)) (-RRB- -RRB-)))))))) (. .)))
(S1 (S (S (NP (NP (NNS Overexpressions)) (PP (IN of) (NP (CC both) (NP (NN Forkhead) (NN Box) (NN M1) (NN transcription) (NN factor)) (CC and) (NP (JJ nuclear) (NN factor-kappaB))))) (VP (VBD were) (VP (VBN associated) (PP (IN with) (NP (NP (JJ worse) (JJ overall) (NN survival)) (PRN (-LRB- -LRB-) (S (NP (NN P)) (VP (JJ =) (NP (NP (CD .041)) (CC and) (NP (NP (NN P) (CD <)) (CD .001))) (, ,) (ADVP (RB respectively)))) (-RRB- -RRB-))))))) (. .)))
(S1 (S (S (NP (JJ Multivariate) (NN Cox) (NN regression) (NN analysis)) (VP (VBD showed) (SBAR (IN that) (S (NP (NP (NN T) (NN stage)) (, ,) (NP (NN lymph) (NN node) (NN metastasis)) (, ,) (CC and) (NP (JJ nuclear) (NN factor-kappaB))) (VP (VBD were) (NP (NP (JJ independent) (JJ prognostic) (NNS factors)) (PP (IN for) (NP (JJ laryngeal) (JJ squamous) (NN cell) (NN carcinoma)))) (PRN (-LRB- -LRB-) (S (NP (NP (NP (NN P)) (VP (VBG =) (NP (CD .038)))) (, ,) (NP (NP (NN P)) (ADJP (JJ =) (NP (CD .014)))) (, ,) (CC and) (NP (NN P))) (VP (JJ =) (NP (NN .005)) (, ,) (ADVP (RB respectively)))) (-RRB- -RRB-))))))) (. .)))
(S1 (S (S (ADVP (RB Furthermore)) (, ,) (NP (DT a) (JJ significant) (NN correlation)) (VP (VBD was) (VP (VBN observed) (PP (IN between) (NP (NP (NN Forkhead) (NN Box) (NN M1) (NN transcription) (NN factor)) (CC and) (NP (NP (JJ nuclear) (NN factor-kappaB)) (PRN (-LRB- -LRB-) (NP (NN rs) (JJ =) (NN 0.683) (, ,) (NN P) (JJ <) (CD .001)) (-RRB- -RRB-))))) (, ,) (S (VP (VBG indicating) (NP (NP (DT the) (JJ potential) (ADJP (ADJP (JJ direct)) (CC or) (ADJP (JJ indirect))) (NN interaction)) (PP (IN between) (NP (PRP them))))))))) (. .)))
(S1 (S (S (PP (IN In) (NP (NN conclusion))) (, ,) (NP (PRP$ our) (NNS results)) (VP (VBP suggest) (SBAR (IN that) (S (S (NP (NP (NP (NNS overexpressions)) (PP (IN of) (NP (NP (NN Forkhead) (NN Box) (NN M1) (NN transcription) (NN factor)) (CC and) (NP (JJ nuclear) (NN factor-kappaB))))) (CC and) (NP (NP (DT the) (JJ possible) (NN interaction)) (PP (IN between) (NP (PRP them))))) (VP (MD may) (VP (VB play) (NP (JJ important) (NNS roles)) (PP (IN in) (NP (NP (DT the) (NP (NN development)) (CC and) (NP (NN progression))) (PP (IN of) (NP (JJ laryngeal) (JJ squamous) (NN cell) (NN carcinoma)))))))) (, ,) (CC and) (S (NP (NP (NN Forkhead) (NN Box) (NN M1) (NN transcription) (NN factor)) (CC and) (NP (JJ nuclear) (NN factor-kappaB))) (VP (MD may) (VP (VB serve) (PP (IN as) (NP (NP (JJ useful) (JJ prognostic) (NNS markers)) (PP (IN for) (NP (JJ laryngeal) (JJ squamous) (NN cell) (NN carcinoma)))))))))))) (. .)))
